Onartuzumab

Onartuzumab
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target scatter factor receptor kinase
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
Chemical and physical data
Formula C4422H6820N1168O1363S31
Molar mass 99.1 kg/mol
 ☒N☑Y (what is this?)  (verify)

Onartuzumab is a humanized monoclonal antibody designed for the treatment of cancer.[1]

Onartuzumab was developed by Genentech, Inc.

References

  1. ↑ "Statement On A Nonproprietary Name Adopted By The USAN Council: Onartuzumab" (PDF). American Medical Association.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.